West Pharmaceutical Services (WST)

R&D to Revenue

2.26%

Quarterly · Period ending:

WST logo

WST R&D to Revenue

Latest reported2.26%
WST Quarterly R&D/Revenue (0.00% → 2.26%)
High-resolution chart · PNG

WST r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
26.8061%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.